ArticleMedicine2026

DOACs reduce risk for new-onset portal hypertension in patients with cirrhosis and atrial fibrillation: A retrospective cohort study.

Yunjuan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.